RRM2 and neoplasm: By examining the correlations between RRM2 and abundance of tumor-infiltrating immune cells, including myeloid and lymphoid lineages, across 33 cancer types, we observed that the levels of M0 and M1 macrophages, activated CD4+ T cells, and T follicular helper cells were consistently positive in more than 10 types of cancers.